Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
03/2004
03/10/2004CN1481376A Oxybenzamides derivatives as factor xa inhibitors
03/10/2004CN1481358A Carboxylic acid amide derivatives and their use in treatment of thromboembolic diseases and tumours
03/10/2004CN1480438A Stable ethene in hibitory compound and its prepn method
03/10/2004CN1141292C Cytostatic agents
03/09/2004US6703524 Organoselenium compounds for cancer chemoprevention
03/09/2004US6703425 Sulfonamide derivatives
03/09/2004US6703422 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; alzheimer's disease; syndrome x; peroxisome proliferator activated receptor-associated disorder
03/09/2004US6703420 Amino-thio-acrylonitriles as MEK inhibitors
03/09/2004US6703368 Peptide-containing α-ketoamide cysteine and serine protease inhibitors
03/04/2004WO2004018448A1 Novel thiophene derivatives, preparation method thereof and pharmaceutical compositions containing same
03/04/2004WO2004018438A2 Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives
03/04/2004WO2004018436A2 Compounds derived from aryl carbamates, preparation thereof and uses of same
03/04/2004WO2004018428A1 Antibacterial benzoic acid derivatives
03/04/2004WO2004018414A2 Antibacterial agents
03/04/2004WO2003075907A3 Small molecule entry inhibitors
03/04/2004WO2003045878A3 2,w-diaminocarboxylic acid compounds
03/04/2004WO2002096867A3 Inhibitors of protein kinase for the treatment of disease
03/04/2004WO2002070469A3 Selective pde3b inhibitors and use of the same in therapy
03/04/2004US20040044251 Optical communication
03/04/2004US20040044224 Reacting nitrobenzonitrile with benzylthiol
03/04/2004US20040044059 Tubulin binding ligands and corresponding prodrug constructs
03/04/2004US20040044051 Cannabinoid receptor agonists
03/04/2004US20040044049 Compounds for inhibiting insulin secretion and methods related thereto
03/04/2004US20040044048 Anticholesterol agents; cardiovascular disorders
03/04/2004US20040044047 Alpha and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
03/04/2004US20040044037 Sleep disorders; antidepressants; analgesics; central nervous system disorders
03/04/2004US20040044008 Dietetics; antilipemic agents; non-insulin dependent diabetes; cardiovascular disorders
03/04/2004US20040043969 Tubulin binding agents and corresponding prodrug constructs
03/04/2004US20040043426 Using "tethering" where potential ligands are covalently bonded or "tethered" to a target and subsequently identified
03/04/2004US20040043326 Information recording medium and oxonol compound
03/04/2004DE10239481A1 New 1-(heterocyclyl-carbonylamino)-cyclopropane-carboxylic acid derivatives, useful as microbicides, especially fungicides or bactericides for protection of plants or materials such as wood
03/04/2004CA2497632A1 Novel thiophene derivatives, preparation method thereof and pharmaceutical compositions containing same
03/04/2004CA2494263A1 Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives
03/03/2004EP1394617A2 Electrophotographic Photosensitive Member, Process Cartridge and Electrophotographic Apparatus
03/03/2004EP1394159A1 New thiophene derivatives, process for their preparation and pharmaceutical compositions containing them
03/03/2004EP1394158A1 Novel compounds and optical elements using the same
03/03/2004EP1394147A1 Carboxylic acid derivative and medicine comprising salt or ester of the same
03/03/2004EP1394140A1 Enantioselektive Reformatsky-Process for the preparation of optically active alcohols, amines and their derivatives
03/03/2004EP1392676A2 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands
03/03/2004EP1392675A1 Substituted oxime derivatives and the use thereof as latent acids
03/03/2004EP1392674A1 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors
03/03/2004EP1392673A2 1,3-dihydroxybenzene derivatives and colorants containing said compounds
03/03/2004EP1392672A1 Chloromethylation of thiophene
03/03/2004EP1392660A1 Substituted benzoylcyclohexenones and their use as herbicidal agents
03/03/2004EP1392655A2 Potassium channel openers
03/03/2004EP1392644A1 Cinnamide derivatives as kcnq potassium channel modulators
03/03/2004EP1392643A2 Trisubstituted-n- (1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors
03/03/2004EP1392642A2 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
03/03/2004EP1392641A1 Substituted cyclohexane-1,4-diamine derivatives
03/03/2004EP1392637A2 Modulators of peroxisome proliferator activated receptors
03/03/2004EP1392304A1 Use of benzothiophenes to treat and prevent prostate cancer
03/03/2004EP1392256A1 Improved transdermal therapeutic system for the treatment of parkinson's disese
03/03/2004EP0929217B1 Sordarin derivatives
03/03/2004CN1479736A Benzofuran and benzothiophene derivatives
03/03/2004CN1479734A Arylated furane and thenoyl amine with potassium channel blocking effect
03/03/2004CN1479721A Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
03/03/2004CN1479716A Propionic acid derivatives with PPAR-alpha activating properties
03/03/2004CN1478472A 细胞粘连抑制剂 Cell adhesion inhibitor
03/02/2004US6699994 Biaryl compounds as serine protease inhibitors
03/02/2004US6699898 Method of treating coronary artery disease or other cetp-mediated disorders in a subject by administering a therapeutically effective amount of a compound of one of claims
03/02/2004US6699893 Glucocorticoid receptor modulators
03/02/2004US6699891 Npyy5 antagonists
03/02/2004US6699890 Phosphodiesterase 4 inhibitors
03/02/2004US6699467 As carriers for delivering active agents such as peptides, drugs by administration, such as oral, subcutaneous, sublingual, and intranasal administration
02/2004
02/26/2004WO2004016603A1 Process for producing n-monoalkyl-3-hydroxy-3-(2-thienyl)propanamine and intermediate
02/26/2004WO2004016576A1 Fused benzene derivative and use
02/26/2004WO2004016221A2 Sulfonamides as potassium channel blockers
02/26/2004WO2003104217A3 Prodrugs of excitatory amino acids
02/26/2004WO2003039549A8 Selective antibacterial agents
02/26/2004WO2003006425A9 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
02/26/2004US20040039064 Treating and/or preventing alzheimer's disease and other neurodegenerative diseases; beta-secretase inhibitors
02/26/2004US20040039053 Administering to a patient a (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives or salt, free of its (+) stereoisomer to treat the type II diabetes, gout, insulin resistance and atherosclerosis
02/26/2004US20040039043 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials
02/26/2004US20040039034 Hydroxypropyl amides for the treatment of Alzheimer's disease
02/26/2004US20040038976 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis.
02/26/2004US20040038858 Carboxamide derivatives and their use in the treatment of thromboembolic diseases and tumours
02/26/2004US20040037802 Activated polymeric bicine derivatives such as polypeptides modified with these polymers exhibit reduced immunogenicity/antigenicity and circulate in the blood
02/26/2004US20040037022 Aminoalcohol derivatives
02/26/2004DE10232020A1 Neurorezeptoraktive Heteroarencarboxamide Neuroreceptor Active Heteroarencarboxamide
02/26/2004CA2495956A1 Sulfonamides as potassium channel blockers
02/26/2004CA2495383A1 Fused benzene derivative and use
02/25/2004EP1391952A2 Salts of pentacyclic or tetrapentaline derived anions, and their uses as ionic conductive materials
02/25/2004EP1391199A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient
02/25/2004EP1390344A2 Organic compounds
02/25/2004EP1390340A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
02/25/2004EP1390036A1 Prostanoic acid derivatives as agents for lowering intraocular pressure
02/25/2004EP1222171B1 Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
02/25/2004EP1200426B1 Substituted thiene-3-yl-sulfonyl amino(thio)carbonyl-triazolin(thi)ones
02/25/2004EP1165064B1 Novel inhibitors of formation of advanced glycation endproducts (age's)
02/25/2004EP1087934B1 Aminocyclohexyl ether compounds and uses thereof
02/25/2004EP1040108B1 Ortho-anthranilamide derivatives as anti-coagulants
02/25/2004CN1478089A Substituted derivatives of aminofuran-2-Y1-acetic acid and aminothien-2-Y1-acetic acid and use thereof for treating migraines and pain
02/25/2004CN1478088A Benzothiophene derivative compounds, process of preparation and use thereof
02/25/2004CN1478067A O-substituted 6-methyl-tramadol derivatives
02/25/2004CN1139587C Cosmetic preparation containing light stable UV-A light filter agent
02/24/2004US6696573 Synthesis of such as 2-(n-(2-(9h-carbazol-2-yloxy)ethyl))-amino-1-((3 -methylsulfonylamino)phenyl)ethanol with enhanced optical purity
02/24/2004US6696494 α-hydroxyarylbutanamine inhibitors of aspartyl protease
02/24/2004US6696487 Fungicidal phenyl(thio)urea and phenyl(thio)carbamate derivatives
02/24/2004US6696472 Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
02/24/2004US6696447 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain